PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030 PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030

Derivative OPTION Pick: BUY PERSISTENT (EXP SEP) 5200 PUT AT 90.90SL 69TGT 160TIME FRAME: 1-3 DAYS(NR) Derivative OPTION Pick: BUY PERSISTENT (EXP SEP) 5200 PUT […]

FII Net (21-05-2024): -1875DII Net (21-05-2024): +3549 FII DATA FII Net (21-05-2024): -1875 DII Net (21-05-2024): +3549 FII DATA Please follow and like us: